Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
- PMID: 15121408
- DOI: 10.1016/S0140-6736(04)16104-7
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Abstract
Adult bone-marrow-derived mesenchymal stem cells are immunosuppressive and prolong the rejection of mismatched skin grafts in animals. We transplanted haploidentical mesenchymal stem cells in a patient with severe treatment-resistant grade IV acute graft-versus-host disease of the gut and liver. Clinical response was striking. The patient is now well after 1 year. We postulate that mesenchymal stem cells have a potent immunosuppressive effect in vivo.
Comment in
-
Immunomodulatory functions of mesenchymal stem cells.Lancet. 2004 May 1;363(9419):1411-2. doi: 10.1016/S0140-6736(04)16134-5. Lancet. 2004. PMID: 15121399 No abstract available.
-
Mesenchymal stem cells for acute graft-versus-host disease.Lancet. 2008 Aug 30;372(9640):715-6; author reply 716. doi: 10.1016/S0140-6736(08)61299-4. Lancet. 2008. PMID: 18761216 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical